Athe Michael Noel Tsibris, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 20 | 2024 | 6863 | 1.800 |
Why?
|
| Virus Latency | 6 | 2024 | 363 | 1.620 |
Why?
|
| Virus Activation | 2 | 2024 | 322 | 1.480 |
Why?
|
| Drug Resistance, Viral | 6 | 2012 | 862 | 1.110 |
Why?
|
| HIV Infections | 25 | 2024 | 17352 | 0.960 |
Why?
|
| Pyrimidines | 9 | 2022 | 3028 | 0.830 |
Why?
|
| Piperazines | 7 | 2012 | 2523 | 0.740 |
Why?
|
| Leukemia Virus, Murine | 2 | 2011 | 94 | 0.740 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2024 | 4369 | 0.710 |
Why?
|
| Fatigue Syndrome, Chronic | 2 | 2011 | 215 | 0.660 |
Why?
|
| Cyclohexanes | 5 | 2015 | 152 | 0.660 |
Why?
|
| Receptors, CCR5 | 4 | 2015 | 486 | 0.590 |
Why?
|
| Anti-HIV Agents | 10 | 2016 | 4527 | 0.550 |
Why?
|
| Levonorgestrel | 1 | 2015 | 74 | 0.480 |
Why?
|
| HIV Fusion Inhibitors | 3 | 2013 | 82 | 0.470 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2015 | 155 | 0.460 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2015 | 116 | 0.460 |
Why?
|
| Triazoles | 5 | 2015 | 903 | 0.460 |
Why?
|
| Xenotropic murine leukemia virus-related virus | 1 | 2011 | 4 | 0.400 |
Why?
|
| Anaplasmosis | 2 | 2015 | 37 | 0.390 |
Why?
|
| Virus Shedding | 1 | 2012 | 111 | 0.380 |
Why?
|
| Virus Internalization | 2 | 2012 | 497 | 0.370 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2011 | 37 | 0.360 |
Why?
|
| HIV Seropositivity | 3 | 2023 | 960 | 0.360 |
Why?
|
| Retroviridae Infections | 1 | 2010 | 147 | 0.350 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2022 | 2199 | 0.340 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2450 | 0.340 |
Why?
|
| Viral Load | 7 | 2023 | 3332 | 0.330 |
Why?
|
| Cervix Uteri | 1 | 2012 | 570 | 0.300 |
Why?
|
| Tumor Virus Infections | 1 | 2010 | 438 | 0.290 |
Why?
|
| RNA, Viral | 6 | 2023 | 2846 | 0.280 |
Why?
|
| Simian immunodeficiency virus | 1 | 2011 | 809 | 0.270 |
Why?
|
| Vagina | 1 | 2012 | 838 | 0.270 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 857 | 0.250 |
Why?
|
| Ionomycin | 1 | 2024 | 110 | 0.240 |
Why?
|
| DNA, Viral | 4 | 2021 | 2202 | 0.240 |
Why?
|
| Virus Replication | 1 | 2012 | 2435 | 0.230 |
Why?
|
| Paraparesis, Tropical Spastic | 1 | 2023 | 32 | 0.220 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 652 | 0.220 |
Why?
|
| Proviruses | 2 | 2023 | 313 | 0.220 |
Why?
|
| Herpesvirus 4, Human | 1 | 2009 | 1078 | 0.220 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2023 | 142 | 0.210 |
Why?
|
| Postmenopause | 1 | 2012 | 2513 | 0.210 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2009 | 612 | 0.200 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2024 | 774 | 0.200 |
Why?
|
| Exanthema | 2 | 2023 | 503 | 0.180 |
Why?
|
| Viral Tropism | 1 | 2021 | 102 | 0.180 |
Why?
|
| Alkynes | 1 | 2021 | 320 | 0.180 |
Why?
|
| Entropy | 2 | 2011 | 210 | 0.170 |
Why?
|
| Cyclopropanes | 1 | 2021 | 432 | 0.170 |
Why?
|
| Lymphoma | 1 | 2009 | 1901 | 0.170 |
Why?
|
| Benzoxazines | 1 | 2021 | 316 | 0.170 |
Why?
|
| Nitriles | 2 | 2022 | 971 | 0.160 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 17635 | 0.160 |
Why?
|
| RNA Splice Sites | 1 | 2020 | 211 | 0.160 |
Why?
|
| HIV Envelope Protein gp120 | 3 | 2012 | 914 | 0.160 |
Why?
|
| Macrophages, Alveolar | 1 | 2021 | 412 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 4740 | 0.150 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2020 | 439 | 0.150 |
Why?
|
| Spermatozoa | 1 | 2021 | 630 | 0.140 |
Why?
|
| Anti-Retroviral Agents | 2 | 2021 | 1784 | 0.140 |
Why?
|
| Viral Envelope Proteins | 2 | 2011 | 640 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 2020 | 0.130 |
Why?
|
| Lab-On-A-Chip Devices | 3 | 2018 | 432 | 0.130 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2018 | 330 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2017 | 2571 | 0.130 |
Why?
|
| Borrelia Infections | 1 | 2015 | 17 | 0.130 |
Why?
|
| Borrelia | 1 | 2015 | 66 | 0.120 |
Why?
|
| Humans | 41 | 2024 | 761572 | 0.120 |
Why?
|
| Mycobacterium bovis | 1 | 2015 | 147 | 0.120 |
Why?
|
| Viremia | 3 | 2023 | 707 | 0.120 |
Why?
|
| Alternative Splicing | 1 | 2020 | 1093 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 1459 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 1844 | 0.120 |
Why?
|
| Metal Nanoparticles | 1 | 2018 | 399 | 0.120 |
Why?
|
| HIV Seronegativity | 1 | 2015 | 211 | 0.110 |
Why?
|
| Pyrazoles | 2 | 2022 | 2009 | 0.110 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2011 | 202 | 0.110 |
Why?
|
| Receptors, CXCR4 | 2 | 2016 | 727 | 0.110 |
Why?
|
| BCG Vaccine | 1 | 2015 | 369 | 0.100 |
Why?
|
| Malaria, Falciparum | 1 | 2021 | 1077 | 0.100 |
Why?
|
| Electricity | 1 | 2013 | 181 | 0.100 |
Why?
|
| Amides | 2 | 2011 | 449 | 0.100 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 1 | 2011 | 62 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 2 | 2020 | 902 | 0.100 |
Why?
|
| Drug Interactions | 2 | 2021 | 1416 | 0.100 |
Why?
|
| Administration, Intravaginal | 1 | 2011 | 150 | 0.100 |
Why?
|
| Contraception | 1 | 2015 | 349 | 0.100 |
Why?
|
| Asthenia | 1 | 2011 | 16 | 0.100 |
Why?
|
| RNA Stability | 1 | 2013 | 329 | 0.090 |
Why?
|
| Epithelium | 1 | 2016 | 1603 | 0.090 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 803 | 0.090 |
Why?
|
| Mutation | 5 | 2020 | 30054 | 0.090 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2012 | 303 | 0.090 |
Why?
|
| Sweating | 1 | 2011 | 155 | 0.090 |
Why?
|
| Female | 20 | 2024 | 392686 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2013 | 1085 | 0.080 |
Why?
|
| Transplantation Immunology | 1 | 2010 | 532 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 3808 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 3359 | 0.080 |
Why?
|
| Pneumonia, Bacterial | 1 | 2011 | 317 | 0.070 |
Why?
|
| Genome, Viral | 1 | 2011 | 667 | 0.070 |
Why?
|
| Cell Line | 2 | 2012 | 15601 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 20099 | 0.070 |
Why?
|
| Educational Status | 1 | 2015 | 2522 | 0.070 |
Why?
|
| Adult | 13 | 2024 | 221203 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 1802 | 0.070 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 650 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1835 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2009 | 992 | 0.060 |
Why?
|
| Male | 15 | 2024 | 360842 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 6075 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9420 | 0.060 |
Why?
|
| Macaca mulatta | 1 | 2011 | 2329 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2009 | 2180 | 0.060 |
Why?
|
| Travel | 1 | 2010 | 796 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2009 | 868 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2011 | 1804 | 0.060 |
Why?
|
| Phylogeny | 1 | 2012 | 2811 | 0.060 |
Why?
|
| Base Sequence | 2 | 2020 | 12441 | 0.060 |
Why?
|
| Pneumonia | 1 | 2016 | 2143 | 0.060 |
Why?
|
| Kinetics | 1 | 2011 | 6374 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 2748 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2016 | 3677 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 6312 | 0.060 |
Why?
|
| DNA Primers | 1 | 2008 | 2819 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2010 | 962 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2008 | 1519 | 0.050 |
Why?
|
| Massachusetts | 2 | 2020 | 8830 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13446 | 0.050 |
Why?
|
| Middle Aged | 8 | 2024 | 220920 | 0.050 |
Why?
|
| Biological Evolution | 1 | 2009 | 1071 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 2151 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2013 | 2180 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 12975 | 0.050 |
Why?
|
| Dyspnea | 1 | 2011 | 1347 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2009 | 2644 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2015 | 2017 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2012 | 5112 | 0.050 |
Why?
|
| Bone Density | 1 | 2015 | 3551 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2011 | 3442 | 0.050 |
Why?
|
| HIV-2 | 1 | 2022 | 156 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 4580 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2013 | 1959 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 1 | 2021 | 361 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3701 | 0.050 |
Why?
|
| Sulfuric Acid Esters | 1 | 2020 | 32 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2010 | 1157 | 0.040 |
Why?
|
| Time-Lapse Imaging | 1 | 2021 | 194 | 0.040 |
Why?
|
| Lung | 2 | 2016 | 10002 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2021 | 248 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2021 | 698 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 39970 | 0.040 |
Why?
|
| Health Behavior | 1 | 2010 | 2644 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 1964 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 595 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 583 | 0.040 |
Why?
|
| Neutrophils | 1 | 2011 | 3767 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2022 | 965 | 0.040 |
Why?
|
| Fever | 2 | 2015 | 1618 | 0.040 |
Why?
|
| Platinum | 1 | 2018 | 220 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 3205 | 0.030 |
Why?
|
| Aged | 6 | 2020 | 169310 | 0.030 |
Why?
|
| Microscopy | 1 | 2021 | 903 | 0.030 |
Why?
|
| Chills | 1 | 2015 | 17 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 4016 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1674 | 0.030 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2015 | 63 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2012 | 9177 | 0.030 |
Why?
|
| Leukopenia | 1 | 2015 | 213 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2013 | 5336 | 0.030 |
Why?
|
| Genitalia, Female | 1 | 2016 | 147 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3763 | 0.030 |
Why?
|
| HIV | 1 | 2022 | 1582 | 0.030 |
Why?
|
| Norpregnenes | 1 | 1994 | 6 | 0.030 |
Why?
|
| Borrelia burgdorferi | 1 | 2015 | 183 | 0.030 |
Why?
|
| Ethinyl Estradiol | 1 | 1994 | 113 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 615 | 0.030 |
Why?
|
| Dielectric Spectroscopy | 1 | 2013 | 30 | 0.030 |
Why?
|
| Pelvic Bones | 1 | 2015 | 270 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 1994 | 263 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2726 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5672 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 1126 | 0.020 |
Why?
|
| Histones | 1 | 2022 | 2580 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 702 | 0.020 |
Why?
|
| Ritonavir | 1 | 2013 | 329 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1994 | 554 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2012 | 243 | 0.020 |
Why?
|
| Plasmodium falciparum | 1 | 2021 | 1742 | 0.020 |
Why?
|
| Cadherins | 1 | 2016 | 903 | 0.020 |
Why?
|
| HIV Protease Inhibitors | 1 | 2013 | 432 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4280 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3208 | 0.020 |
Why?
|
| Body Weight | 1 | 2021 | 4618 | 0.020 |
Why?
|
| Aviation | 1 | 2010 | 49 | 0.020 |
Why?
|
| Fluorescence | 1 | 2013 | 756 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1971 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 1469 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 26127 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 3156 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2015 | 783 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3826 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4575 | 0.020 |
Why?
|
| DNA | 1 | 2022 | 7213 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 5035 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5791 | 0.020 |
Why?
|
| Fatigue | 1 | 2015 | 1552 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 41493 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 1739 | 0.020 |
Why?
|
| Headache | 1 | 2015 | 1256 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1386 | 0.020 |
Why?
|
| Young Adult | 3 | 2021 | 59255 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2016 | 2639 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 6965 | 0.010 |
Why?
|
| Software | 1 | 2018 | 4434 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 1937 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14607 | 0.010 |
Why?
|
| Data Collection | 1 | 2013 | 3322 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6766 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2013 | 1978 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14666 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7581 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2223 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22176 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15843 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2010 | 1126 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 1886 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9489 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3204 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 12059 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10773 | 0.010 |
Why?
|
| Hospitalization | 1 | 2020 | 10721 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10508 | 0.010 |
Why?
|
| Health Surveys | 1 | 2010 | 4061 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8656 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 18965 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2013 | 8633 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 168467 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 14032 | 0.010 |
Why?
|
| Developing Countries | 1 | 2010 | 2885 | 0.010 |
Why?
|
| Boston | 1 | 2010 | 9326 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8002 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13510 | 0.010 |
Why?
|
| United States | 2 | 2013 | 72335 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 29876 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39107 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1994 | 1178 | 0.010 |
Why?
|
| Fasting | 1 | 1994 | 1603 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2013 | 64684 | 0.000 |
Why?
|
| Adolescent | 2 | 2010 | 88324 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 58986 | 0.000 |
Why?
|
| Child | 1 | 2010 | 80156 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1994 | 6391 | 0.000 |
Why?
|
| Insulin | 1 | 1994 | 6597 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1994 | 54426 | 0.000 |
Why?
|